CORC

在结果中检索

CORC

浏览/检索结果: 共11条，第1-10条 帮助

已选(0)清除 条数/页：   排序方式：
A phase I study of the safety and activity of K-001 in patients with advanced pancreatic ductal adenocarcinoma 期刊论文
BMC Cancer, 2021, 卷号: 21, 期号: 1
作者:  Cui,Jiujie;  Yang,Haiyan;  Liu,Jue;  Chen,Donghui;  Hu,Jiong
收藏  |  浏览/下载：85/0  |  提交时间：2021/06/15
Phase I dose-escalation study of chiauranib, a novel angiogenic, mitotic, and chronic inflammation inhibitor, in patients with advanced solid tumors 期刊论文
2019, 卷号: 12, 期号: 1, 页码: 9
作者:  Sun, Yongkun;  Yang, Lin;  Hao, Xuezhi;  Liu, Yutao;  Zhang, Jinwen
收藏  |  浏览/下载：1/0  |  提交时间：2020/01/03
A prospective phase I study of hypo-fractionated neoadjuvant radiotherapy for locally advanced gastric cancer 期刊论文
2018, 卷号: 18, 期号: 1, 页码: 803
作者:  Li, Ning;  Wang, Xin;  Tang, Yuan;  Zhao, Dongbing;  Chi, Yihebali
收藏  |  浏览/下载：9/0  |  提交时间：2020/01/03
S-1 chemotherapy and intensity-modulated radiotherapy after D1/D2 lymph node dissection in patients with node-positive gastric cancer: a phase I/II study 期刊论文
2018, 卷号: 118, 期号: 3, 页码: 338-343
作者:  Wang, X.;  Zhao, D. B.;  Yang, L.;  Chi, Y.;  Tang, Y.
收藏  |  浏览/下载：4/0  |  提交时间：2020/01/03
A phase I study of different doses and frequencies of pegylated recombinant human granulocyte-colony stimulating factor (PEG rhG-CSF) in patients with standard-dose chemotherapy-induced neutropenia 期刊论文
2017, 卷号: 29, 期号: 5, 页码: 402-410
作者:  Qin, Yan;  Han, Xiaohong;  Wang, Lin;  Du, Ping;  Yao, Jiarui
收藏  |  浏览/下载：4/0  |  提交时间：2020/01/03
Phase I/II Study of AC0010, Mutant Selective EGFR Inhibitor, in Non-Small Cell Lung Cancer (NSCLC) Patients with EGFR T790M Mutation 期刊论文
2017, 卷号: 12, 期号: 1, 页码: S437-S438
作者:  Wu, Yi Long;  Zhou, Qing;  Liu, Xiaoqing;  Zhang, Li;  Zhou, Jianying
收藏  |  浏览/下载：3/0  |  提交时间：2020/01/03
Safety, pharmacokinetics, and antitumor properties of anlotinib, an oral multi-target tyrosine kinase inhibitor, in patients with advanced refractory solid tumors 期刊论文
JOURNAL OF HEMATOLOGY & ONCOLOGY, 2016, 卷号: 9
作者:  Sun, Yongkun;  Niu, Wei;  Du, Feng;  Du, Chunxia;  Li, Shuting
收藏  |  浏览/下载：37/0  |  提交时间：2019/01/08
A Phase I study of safety and pharmacokinetics of fruquintinib, a novel selective inhibitor of vascular endothelial growth factor receptor-1,-2, and-3 tyrosine kinases in Chinese patients with advanced solid tumors 期刊论文
CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2016, 卷号: 78, 期号: 2
作者:  Cao, Junning;  Zhang, Jian;  Peng, Wei;  Chen, Zhiyu;  Fan, Songhua
收藏  |  浏览/下载：3/0  |  提交时间：2019/12/06
Safety, pharmacokinetics, and antitumor properties of anlotinib, an oral multi-target tyrosine kinase inhibitor, in patients with advanced refractory solid tumors 期刊论文
2016, 卷号: 9, 期号: 1, 页码: 105
作者:  Sun, Yongkun;  Niu, Wei;  Du, Feng;  Du, Chunxia;  Li, Shuting
收藏  |  浏览/下载：4/0  |  提交时间：2020/01/04
Phase I study of chimeric anti-CD20 monoclonal antibody in Chinese patients with CD20-positive non-Hodgkin's lymphoma 期刊论文
2016, 卷号: 28, 期号: 2, 页码: 197-208
作者:  Gui, Lin;  Han, Xiaohong;  He, Xiaohui;  Song, Yuanyuan;  Yao, Jiarui
收藏  |  浏览/下载：3/0  |  提交时间：2020/01/04

©版权所有 ©2017 CSpace - Powered by CSpace